Privia Health Group (NASDAQ:PRVA) Stock Price Expected to Rise, Barclays Analyst Says

Privia Health Group (NASDAQ:PRVA) had its price target raised by equities research analysts at Barclays from $22.00 to $23.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “equal weight” rating on the stock. Barclays‘s price target would suggest a potential downside of 0.74% from the company’s previous close.

PRVA has been the topic of several other reports. Piper Sandler cut their target price on Privia Health Group from $36.00 to $35.00 and set an “overweight” rating on the stock in a report on Monday, August 11th. Evercore ISI increased their price objective on Privia Health Group from $28.00 to $30.00 and gave the company an “outperform” rating in a report on Friday. Truist Financial reissued a “buy” rating and issued a $31.00 price objective (up from $30.00) on shares of Privia Health Group in a research note on Monday. Stephens reaffirmed an “overweight” rating and set a $32.00 target price on shares of Privia Health Group in a research report on Wednesday, September 24th. Finally, Citigroup reiterated an “outperform” rating on shares of Privia Health Group in a report on Friday, August 29th. Twelve analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $29.58.

Privia Health Group Stock Performance

Shares of NASDAQ PRVA traded down $0.26 during trading hours on Monday, hitting $23.17. The stock had a trading volume of 515,669 shares, compared to its average volume of 846,552. The company has a market capitalization of $2.85 billion, a P/E ratio of 178.28, a P/E/G ratio of 3.32 and a beta of 0.83. Privia Health Group has a 52 week low of $18.77 and a 52 week high of $26.51. The firm’s 50-day moving average price is $24.15 and its two-hundred day moving average price is $22.76.

Privia Health Group (NASDAQ:PRVA) last released its quarterly earnings results on Tuesday, June 7th. The company reported $0.10 earnings per share for the quarter. Privia Health Group had a net margin of 0.89% and a return on equity of 2.52%. The business had revenue of $213.61 million for the quarter. As a group, analysts expect that Privia Health Group will post 0.14 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. CWM LLC grew its stake in shares of Privia Health Group by 50.3% in the first quarter. CWM LLC now owns 1,804 shares of the company’s stock worth $40,000 after acquiring an additional 604 shares during the last quarter. Russell Investments Group Ltd. raised its stake in Privia Health Group by 2,852.2% during the 1st quarter. Russell Investments Group Ltd. now owns 2,657 shares of the company’s stock valued at $60,000 after purchasing an additional 2,567 shares during the last quarter. Caitong International Asset Management Co. Ltd boosted its holdings in Privia Health Group by 2,115.3% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 3,323 shares of the company’s stock valued at $75,000 after purchasing an additional 3,173 shares during the period. Vestcor Inc bought a new stake in Privia Health Group in the 1st quarter valued at $76,000. Finally, Canada Pension Plan Investment Board grew its position in Privia Health Group by 48.0% in the 2nd quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock worth $85,000 after purchasing an additional 1,200 shares during the last quarter. 94.48% of the stock is currently owned by institutional investors and hedge funds.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.